Immediate Impact
1 by Nobel laureates 61 standout
Citing Papers
CAR T therapies in multiple myeloma: unleashing the future
2024 Standout
NF-κB in biology and targeted therapy: new insights and translational implications
2024 Standout
Works of Eileen Liao being referenced
Ixazomib, lenalidomide, and dexamethasone in patients with newly diagnosed multiple myeloma: long-term follow-up including ixazomib maintenance
2019
Safety and tolerability of ixazomib, an oral proteasome inhibitor, in combination with lenalidomide and dexamethasone in patients with previously untreated multiple myeloma: an open-label phase 1/2 study
2014
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Eileen Liao | 279 | 289 | 156 | 14 | 344 | |
| Paul Schoen | 258 | 337 | 198 | 9 | 364 | |
| Leah Fink | 265 | 363 | 217 | 15 | 385 | |
| Jill N. Burke | 290 | 231 | 189 | 11 | 372 | |
| Ioannis Panagiotidis | 239 | 228 | 148 | 22 | 370 | |
| M. Mietzel | 305 | 323 | 178 | 16 | 405 | |
| Michelle E. Maglio | 182 | 208 | 146 | 9 | 349 | |
| Miguel Teodoro Hernández‐Garcia | 256 | 319 | 164 | 10 | 363 | |
| Susanne Strifler | 180 | 232 | 174 | 16 | 329 | |
| Irini Grapsa | 323 | 359 | 181 | 11 | 403 | |
| Ma Teresa Cibeira | 220 | 267 | 150 | 13 | 300 |
All Works
Login with ORCID to disown or claim papers
Loading papers...